Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Revance Therapeutics Inc. (RVNC)

21.25   0.37 (1.77%) 05-22 16:00
Open: 20.95 Pre. Close: 20.88
High: 21.28 Low: 20.54
Volume: 275,028 Market Cap: 1,212M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 21.306 - 21.387 21.387 - 21.469
Low: 20.326 - 20.424 20.424 - 20.522
Close: 21.09 - 21.242 21.242 - 21.394

Technical analysis

as of: 2020-05-24 6:51:35 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 25.44     One year: 29.71
Support: Support1: 17.91    Support2: 15.52
Resistance: Resistance1: 21.78    Resistance2: 25.44
Pivot: 19.77
Moving Average: MA(5): 20.70     MA(20): 19.42
MA(100): 19.49     MA(250): 15.88
MACD: MACD(12,26):     Signal(9): 0.88
Stochastic oscillator: %K(14,3): 81.80     %D(3): 77.57
RSI: RSI(14): 61.84
52-week: High: 27.97  Low: 9.88  Change(%): 94.4
Average Vol(K): 3-Month: 74370  10-Days: 55581

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
RVNC has closed below upper band by 15.8%. Bollinger Bands are 33.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 11 May 2020
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha

Tue, 19 May 2020
Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices - Business Wire

Wed, 20 May 2020
A Little Luck Can Go a Long Way with Revance Therapeutics Inc. (RVNC) as it 5-day change was -3.00% - News Daemon

Wed, 20 May 2020
Revance Therapeutics Inc. (RVNC) Soars 1.15% on May 20 - Equities.com

Thu, 30 Apr 2020
Revance to Release First Quarter 2020 Financial Results on Thursday, May 7, 2020 - Business Wire

Sat, 09 May 2020
Revance Therapeutics (RVNC) Q1 2020 Earnings Call Transcript - Motley Fool

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 57
Shares Float (M) 46
% Held by Insiders 1.45
% Held by Institutions 95.68
Shares Short (K) 6,620
Shares Short P. Month (K) 6,940

Stock Financials

EPS -4.000
EPS Est This Year -3.610
EPS Est Next Year -3.410
Book Value (p.s.) 5.410
Profit Margin
Operating Margin -97819.69
Return on Assets (ttm) -25.7
Return on Equity (ttm) -70.3
Qtrly Rev. Growth -79.1
Gross Profit (p.s.) 0.007
Sales Per Share 0.003
EBITDA (p.s.) -3.256
Qtrly Earnings Growth
Operating Cash Flow (M) -138
Levered Free Cash Flow (M) -91

Stock Valuations

PE Ratio -5.31
PEG Ratio
Price to Book value 3.93
Price to Sales 6281.41
Price to Cash Flow -8.78

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.